Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2.

Myotonic dystrophy type 1 Myotonic dystrophy type 2 Nucleus raphe Substantia nigra Transcranial sonography

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 03 09 2023
revised: 06 02 2024
accepted: 21 02 2024
medline: 4 3 2024
pubmed: 4 3 2024
entrez: 4 3 2024
Statut: epublish

Résumé

Myotonic dystrophy type 1 (DM1) and 2 (DM2) are genetically determined progressive muscular disorders with multisystemic affection, including brain involvement. Transcranial sonography (TCS) is a reliable diagnostic tool for the investigation of deep brain structures. We sought to evaluate TCS findings in genetically confirmed DM1 and DM2 patients, and further correlate these results with patients' clinical features. This cross-sectional study included 163 patients (102 DM1, 61 DM2). Echogenicity of the brainstem raphe (BR) and substantia nigra (SN) as well as the diameter of the third ventricle (DTV) were assessed by TCS. Patients were evaluated using the Hamilton Depression Rating Scale, Fatigue Severity Scale and Daytime Sleepiness Scale. SN hyperechogenicity was observed in 40% of DM1 and 34% of DM2 patients. SN hypoechogenicity was detected in 17% of DM1 and 7% of DM2 patients. BR hypoechogenicity was found in 36% of DM1 and 47% of DM2 subjects. Enlarged DTV was noted in 19% of DM1 and 15% of DM2 patients. Older, weaker, depressive, and fatigued DM1 patients were more likely to have BR hypoechogenicity (p < 0.05). DTV correlated with age and disease duration in DM1 (p < 0.01). In DM2 patients SN hyperechogenicity correlated with fatigue. Excessive daytime sleepiness was associated with hypoechogenic BR (p < 0.05) and enlarged DVT (p < 0.01) in DM2 patients. TCS is an easy applicable and sensitive neuroimaging technique that could offer new information regarding several brainstem structures in DM1 and DM2. This may lead to better understanding of the pathogenesis of the brain involvement in DM with possible clinical implications.

Identifiants

pubmed: 38434309
doi: 10.1016/j.heliyon.2024.e26856
pii: S2405-8440(24)02887-1
pmc: PMC10907768
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e26856

Informations de copyright

© 2024 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Milija Mijajlovic reports a relationship with Heliyon that includes: board membership.

Auteurs

Milija Mijajlovic (M)

Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Ivo Bozovic (I)

Neurology Clinic, University Clinical Center of Serbia, Belgrade, Serbia.

Aleksandra Pavlovic (A)

Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Faculty of Special Education and Rehabilitation, University of Belgrade, Belgrade, Serbia.

Vidosava Rakocevic-Stojanovic (V)

Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Sanja Gluscevic (S)

Neurology Clinic, Clinical Center of Montenegro, Podgorica, Montenegro.

Amalija Stojanovic (A)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Ivana Basta (I)

Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Giovanni Meola (G)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Department of Neurorehabilitation Sciences, Casa Di Cura del Policlinico, Milan, Italy.

Stojan Peric (S)

Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Classifications MeSH